Acute Migraine Treatment: Guidelines From the International Headache Society

Michael J. Arnold, MD, MHPE

American Family Physician. 2026;113(2):196-198.

Author disclosure: No relevant financial relationships.

This clinical content conforms to AAFP criteria for CME.

KEY POINTS FOR PRACTICE

• Abortive medications are most effective when taken early in the headache phase. Most medications, including triptans and NSAIDs, are not effective when taken during migraine aura.

• Triptans are more effective than acetaminophen and NSAIDs, but there is limited additional benefit in increasing triptan dose.

• Although menstrual migraines respond less to medications, triptans (with or without NSAIDs) are effective.

• In children, acetaminophen and ibuprofen are more effective than placebo, whereas triptans are not consistently superior.

From the AFP Editors

Migraine headaches are common throughout the world. The International Headache Society (IHS) published guidelines for acute migraine medical treatment.

MEDICATION TIMING

Abortive medications should be taken early in the headache phase while headache intensity is mild. Most medications, including triptans and nonsteroidal anti-inflammatory drugs (NSAIDs), are not effective in the prodrome or aura phase. However, ubrogepant (Ubrelvy) appears to be effective when taken before the headache phase.

When patients experience early vomiting with migraines, nonoral formulations such as subcutaneous injections, intranasal sprays, and suppositories should be considered. Oral disintegrating tablets can also be trialed. Combining antiemetics with triptans or NSAIDs can improve nausea and vomiting, and triptans appear to be more effective than the combination of an NSAID and antiemetic medication.

To prevent medication overuse headache, the IHS recommends limiting the use of analgesics and NSAIDs to 3 days per week and 10 days per month. For triptans and combined analgesics, the recommendation is to limit use to 2 days per week and 8 days per month.

MEDICATIONS

Analgesics

Analgesic medications, including acetaminophen and NSAIDs, are widely available and can be beneficial for migraine when taken early in the headache course.

Triptans

The triptan class of medications is a more specific treatment for migraines and are more effective than analgesics. However, triptans tend to be less effective in menstrual migraines and those with onset during sleep.

Comparative studies consistently demonstrate that triptans more effectively lead to headache resolution in 2 hours. In one study, 10 mg of rizatriptan (Maxalt) resulted in 2-hour headache resolution in 38% of patients vs 31% with ibuprofen. In two studies, 85 mg of sumatriptan resulted in 2-hour headache resolution in 24% of patients vs 16% with 500 mg of naproxen.

In patients with partial response to triptans, increasing the dose will increase efficacy by 11% or less. Although sumatriptan (oral and intranasal) and eletriptan have demonstrated improved efficacy at higher doses, zolmitriptan has not. The IHS recommends optimizing triptan dosing by ensuring the medication is taken as early as possible and monitoring effectiveness over several migraine episodes.

A triptan is considered effective when it successfully treats 3 of 4 consecutive migraines; switching medications is recommended after failure in 2 of 3 consecutive migraines. The guideline recommends a trial of two other triptans before changing to a different medication class.

Triptans are more effective when combined with fast-release formulations of NSAIDs. Sumatriptan combined with naproxen is supported by the most evidence.

MICHAEL J. ARNOLD, MD, MHPE, Naval Undersea Medical Institute, Groton, Connecticut

Address correspondence to Michael J. Arnold, MD, MHPE, FAAFP, at mkcarnold@gmail.com.

Author disclosure: No relevant financial relationships.

Coverage of guidelines from other organizations does not imply endorsement by AFP or the AAFP.

This series is coordinated by Michael J. Arnold, MD, MHPE, AFP Assistant Medical Editor.

A collection of Practice Guidelines published in AFP is available at https://www.aafp.org/afp/practguide.

Copyright © 2026 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. See permissions for copyright questions and/or permission requests.